17-69152462-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001377321.1(ABCA10):c.4156G>T(p.Val1386Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001377321.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA10 | NM_001377321.1 | c.4156G>T | p.Val1386Phe | missense_variant | 35/39 | ENST00000690296.1 | NP_001364250.1 | |
ABCA10 | NM_080282.4 | c.4156G>T | p.Val1386Phe | missense_variant | 36/40 | NP_525021.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA10 | ENST00000690296.1 | c.4156G>T | p.Val1386Phe | missense_variant | 35/39 | NM_001377321.1 | ENSP00000509702.1 | |||
ABCA10 | ENST00000522406.5 | n.*3084G>T | non_coding_transcript_exon_variant | 37/41 | 1 | ENSP00000429853.1 | ||||
ABCA10 | ENST00000522406.5 | n.*3084G>T | 3_prime_UTR_variant | 37/41 | 1 | ENSP00000429853.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250352Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135264
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461042Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726856
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74258
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at